US EditionChamber of Commerce sues Biden administration over federal control of drug prices
- The U.S. Chamber of Commerce has filed a lawsuit against the federal government over the new law that allows Medicare to negotiate drug prices with pharmaceutical companies. The Chamber argues that the program violates drugmakers' due process rights and would impose excessive penalties on companies who do not accept the set prices.
- The Chamber's lawsuit follows a similar suit filed by Merck & Co earlier in the week, citing concerns over price controls stifling innovation in the pharmaceutical industry and negatively impacting long-term American healthcare.
6 Articles
6 Articles
US Chamber of Commerce Sues Over Government's Drug Pricing Power
Chambers of Commerce Sue to Block Medicare Drug Negotiations
The US Chamber of Commerce and several state and local affiliates are suing the federal government claiming the drug price control provisions of the Inflation Reduction Act are unconstitutional and violate a host of federal laws, including those governing the separation of powers, due process, and the enumerated powers of Congress.
Chamber of Commerce sues Biden administration over federal control of drug prices
The U.S. Chamber of Commerce announced Friday it is suing the Biden administration over the Medicare price negotiation provisions that were included in the Inflation Reduction Act, becoming the second organization to challenge the measure after Merck filed a lawsuit earlier this week. “Government price controls harm patients, limit access to medicine, and stifle American…
Coverage Details
Bias Distribution
- 50% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
